• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

双膦酸盐对破骨细胞的特异性作用的一种可能机制:替鲁膦酸优先影响具有皱褶缘的极化破骨细胞。

A possible mechanism of the specific action of bisphosphonates on osteoclasts: tiludronate preferentially affects polarized osteoclasts having ruffled borders.

作者信息

Murakami H, Takahashi N, Sasaki T, Udagawa N, Tanaka S, Nakamura I, Zhang D, Barbier A, Suda T

机构信息

Department of Biochemistry, School of Dentistry, Showa University, Tokyo, Japan.

出版信息

Bone. 1995 Aug;17(2):137-44. doi: 10.1016/s8756-3282(95)00150-6.

DOI:10.1016/s8756-3282(95)00150-6
PMID:8554921
Abstract

The mechanism of action of tiludronate [(4-chlorophenyl)-thiomethylene bisphosphonate] on osteoclastic bone resorption was examined in mouse culture systems. Tiludronate did not inhibit the formation of osteoclast-like multinucleated cells (OCLs) induced by 1 alpha,25-dihydroxyvitamin D3 in cocultures of mouse osteoblastic cells and bone marrow cells. OCLs obtained from cocultures on collagen gel-coated dishes, treated with tiludronate, formed as many resorption pits on dentine slices as those obtained from the control cocultures. However, pit formation by OCLs was dose-dependently inhibited when tiludronate was added directly to the pit formation assay. Other bisphosphonates such as alendronate and etidronate dose-dependently inhibited pit formation according to the in vivo potencies of the respective bisphosphonates to inhibit bone resorption. However, they had no inhibitory effect on the recruitment of OCLs induced by 1 alpha,25-dihydroxyvitamin D3 in the cocultures. When OCLs were placed on dentine slices, they formed the ringed structure of F-actin-containing podosomes and ruffled borders (polarized OCLs) even in the presence of tiludronate. However, the actin rings in OCLs were disrupted by the addition of tiludronate soon after they began to resorb dentine. In contrast, OCLs placed on collagen gel formed neither actin rings nor ruffled borders (nonpolarized OCLs), and showed no response to tiludronate. OCLs formed from the spleen cells of osteosclerotic (oc/oc) mice developed the ringed structure of podosomes, but not ruffled borders, on dentine slices. The actin ring in the oc/oc spleen cell-derived OCLs placed on dentine slices was not disrupted by the addition of tiludronate.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

在小鼠培养系统中研究了替鲁膦酸[(4-氯苯基)-硫亚甲基双膦酸酯]对破骨细胞性骨吸收的作用机制。在小鼠成骨细胞和骨髓细胞共培养体系中,替鲁膦酸不抑制1α,25-二羟基维生素D3诱导的破骨细胞样多核细胞(OCLs)的形成。从胶原凝胶包被培养皿上的共培养物中获得的OCLs,用替鲁膦酸处理后,在牙本质切片上形成的吸收陷窝数量与对照共培养物获得的OCLs形成的吸收陷窝数量相同。然而,当直接将替鲁膦酸添加到陷窝形成试验中时,OCLs形成陷窝的能力呈剂量依赖性受到抑制。其他双膦酸盐如阿仑膦酸和依替膦酸根据各自双膦酸盐体内抑制骨吸收的效力呈剂量依赖性抑制陷窝形成。然而,它们对共培养物中1α,25-二羟基维生素D3诱导的OCLs募集没有抑制作用。当OCLs置于牙本质切片上时,即使存在替鲁膦酸,它们也会形成含F-肌动蛋白的足突体和皱褶缘的环状结构(极化OCLs)。然而,OCLs开始吸收牙本质后不久,添加替鲁膦酸会破坏OCLs中的肌动蛋白环。相反,置于胶原凝胶上的OCLs既不形成肌动蛋白环也不形成皱褶缘(非极化OCLs),并且对替鲁膦酸无反应。由骨硬化(oc/oc)小鼠的脾细胞形成的OCLs在牙本质切片上形成足突体的环状结构,但不形成皱褶缘。置于牙本质切片上的oc/oc脾细胞来源的OCLs中的肌动蛋白环不会因添加替鲁膦酸而被破坏。(摘要截短于250字)

相似文献

1
A possible mechanism of the specific action of bisphosphonates on osteoclasts: tiludronate preferentially affects polarized osteoclasts having ruffled borders.双膦酸盐对破骨细胞的特异性作用的一种可能机制:替鲁膦酸优先影响具有皱褶缘的极化破骨细胞。
Bone. 1995 Aug;17(2):137-44. doi: 10.1016/s8756-3282(95)00150-6.
2
Tiludronate inhibits protein tyrosine phosphatase activity in osteoclasts.替鲁膦酸盐抑制破骨细胞中的蛋白酪氨酸磷酸酶活性。
Bone. 1997 May;20(5):399-404. doi: 10.1016/s8756-3282(97)00025-2.
3
[Possible mechanism of the specific action of bisphosphonates on osteoclasts].[双膦酸盐对破骨细胞特异性作用的可能机制]
Nihon Rinsho. 2003 Feb;61(2):207-12.
4
Destruxins, cyclodepsipeptides, block the formation of actin rings and prominent clear zones and ruffled borders in osteoclasts.destruxins(环缩肽)会阻碍破骨细胞中肌动蛋白环、明显的透明区和褶皱边缘的形成。
Bone. 2003 Sep;33(3):443-55. doi: 10.1016/s8756-3282(03)00201-1.
5
Involvement of vacuolar H+ -ATPase in incorporation of risedronate into osteoclasts.液泡H⁺-ATP酶参与利塞膦酸盐进入破骨细胞的过程。
Bone. 2003 Apr;32(4):341-9. doi: 10.1016/s8756-3282(03)00024-3.
6
Wortmannin, a specific inhibitor of phosphatidylinositol-3 kinase, blocks osteoclastic bone resorption.渥曼青霉素,一种磷脂酰肌醇-3激酶的特异性抑制剂,可阻断破骨细胞介导的骨吸收。
FEBS Lett. 1995 Mar 13;361(1):79-84. doi: 10.1016/0014-5793(95)00153-z.
7
The bisphosphonate tiludronate is a potent inhibitor of the osteoclast vacuolar H(+)-ATPase.双膦酸盐替鲁膦酸是破骨细胞液泡H(+)-ATP酶的有效抑制剂。
J Bone Miner Res. 1996 Oct;11(10):1498-507. doi: 10.1002/jbmr.5650111017.
8
Multinucleated cells formed on calcified dentine from mouse bone marrow cells treated with 1 alpha,25-dihydroxyvitamin D3 have ruffled borders and resorb dentine.用1α,25 - 二羟基维生素D3处理的小鼠骨髓细胞在钙化牙本质上形成的多核细胞具有皱褶缘并能吸收牙本质。
Anat Rec. 1989 Jul;224(3):379-91. doi: 10.1002/ar.1092240307.
9
Interleukin 1 induces multinucleation and bone-resorbing activity of osteoclasts in the absence of osteoblasts/stromal cells.白细胞介素1在没有成骨细胞/基质细胞的情况下可诱导破骨细胞的多核化和骨吸收活性。
Exp Cell Res. 1999 Feb 25;247(1):84-93. doi: 10.1006/excr.1998.4320.
10
Lack of bone resorption in osteosclerotic (oc/oc) mice is due to a defect in osteoclast progenitors rather than the local microenvironment provided by osteoblastic cells.
Biochem Biophys Res Commun. 1992 Apr 15;184(1):67-72. doi: 10.1016/0006-291x(92)91158-m.

引用本文的文献

1
Biomaterial Cues for Regulation of Osteoclast Differentiation and Function in Bone Regeneration.用于调节骨再生中破骨细胞分化和功能的生物材料线索
Adv Ther (Weinh). 2025 Jan;8(1). doi: 10.1002/adtp.202400296. Epub 2024 Nov 15.
2
Medication-related osteonecrosis of the jaw (MRONJ): a review of pathogenesis hypothesis and therapy strategies.药物相关性下颌骨坏死(MRONJ):发病机制假说和治疗策略的综述。
Arch Toxicol. 2024 Mar;98(3):689-708. doi: 10.1007/s00204-023-03653-7. Epub 2023 Dec 28.
3
Advancement in the Treatment of Osteoporosis and the Effects on Bone Healing.
骨质疏松症治疗进展及其对骨愈合的影响
J Clin Med. 2022 Dec 16;11(24):7477. doi: 10.3390/jcm11247477.
4
Ozonated oil effect for prevention of medication-related osteonecrosis of the jaw (MRONJ) in rats undergoing zoledronic acid therapy.臭氧油对唑来膦酸治疗大鼠药物相关性颌骨坏死(MRONJ)的预防作用。
Clin Oral Investig. 2021 Dec;25(12):6653-6659. doi: 10.1007/s00784-021-03951-3. Epub 2021 Apr 25.
5
Zoledronic Acid Is Not Equally Potent on Osteoclasts Generated From Different Individuals.唑来膦酸对不同个体来源的破骨细胞的作用效果并不相同。
JBMR Plus. 2020 Sep 29;4(11):e10412. doi: 10.1002/jbm4.10412. eCollection 2020 Nov.
6
Effect of Preoperative Bisphosphonate Treatment on Fracture Healing after Internal Fixation Treatment of Intertrochanteric Femoral Fractures.术前双膦酸盐治疗对股骨转子间骨折内固定术后骨折愈合的影响。
Hip Pelvis. 2019 Jun;31(2):75-81. doi: 10.5371/hp.2019.31.2.75. Epub 2019 May 30.
7
Combined effect of recombinant human bone morphogenetic protein-2 and low level laser irradiation on bisphosphonate-treated osteoblasts.重组人骨形态发生蛋白-2与低强度激光照射对双膦酸盐处理的成骨细胞的联合作用。
J Korean Assoc Oral Maxillofac Surg. 2018 Dec;44(6):259-268. doi: 10.5125/jkaoms.2018.44.6.259. Epub 2018 Dec 28.
8
Effect of local injection of Zolena, zoledronic acid made in Iran, on orthodontic tooth movement and root and bone resorption in rats.伊朗产唑来膦酸(Zolena)局部注射对大鼠正畸牙齿移动及牙根和骨吸收的影响。
J Dent Res Dent Clin Dent Prospects. 2017 Fall;11(4):257-264. doi: 10.15171/joddd.2017.045. Epub 2017 Dec 13.
9
Do topical applications of bisphosphonates improve bone formation in oral implantology? A systematic review.双膦酸盐局部应用是否能改善口腔种植学中的骨形成?一项系统评价。
Med Oral Patol Oral Cir Bucal. 2017 Jul 1;22(4):e512-e519. doi: 10.4317/medoral.21887.
10
Does the Time of Postoperative Bisphosphonate Administration Affect the Bone Union in Osteoporotic Intertrochanteric Fracture of Femur?术后双膦酸盐给药时间是否会影响骨质疏松性股骨转子间骨折的骨愈合?
Hip Pelvis. 2015 Dec;27(4):258-64. doi: 10.5371/hp.2015.27.4.258. Epub 2015 Dec 30.